Emergent BioSolutions gets $14.5M in federal funding to expedite COVID-19 plasma therapy development
Last week, we spoke to the head of Emergent BioSolutions’ Therapeutics Business Unit Dr. Laura Saward about her company’s work developing plasma-based potential treatments for COVID-19. Now, the company announced… »